Hypertrophic cardiomyopathy causes: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
Line 19: | Line 19: | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Atrial myxoma]], [[cardiofaciocutaneous syndrome]], [[congenital generalized lipodystrophy|congenital generalized lipodystrophy type 2]], [[Costello syndrome]], [[hypertension]], [[hypertrichotic osteochondrodysplasia]], [[Noonan syndrome]], subendocardial ischemia, [[very long-chain acyl-CoA dehydrogenase deficiency]], [[Yunis-Varon syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 27: | Line 27: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cardiofaciocutaneous syndrome]], [[congenital generalized lipodystrophy|congenital generalized lipodystrophy type 2]], [[Yunis-Varon syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 39: | Line 39: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Diabetes mellitus]], [[glycogenosis type 2]], [[thyroid disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 47: | Line 47: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Glycogenosis type 2]], [[very long-chain acyl-CoA dehydrogenase deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cardiofaciocutaneous syndrome]], [[congenital generalized lipodystrophy|congenital generalized lipodystrophy type 2]], [[Costello syndrome]], [[cytochrome c oxidase deficiency]], [[Fabry's disease]], [[familial]], [[Friedreich's ataxia]], [[gene mutation]], [[glycogenosis type 2]], [[long-chain acyl-CoA dehydrogenase deficiency]], [[malonyl-CoA decarboxylase deficiency]], [[MELAS]], [[multiple lentigines syndrome]], [[myotonic dystrophy]], [[Noonan syndrome]], sarcomeric protein mutations | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Hereditary spherocytosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 67: | Line 67: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal / Ortho''' | | '''Musculoskeletal / Ortho''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Hypertrichotic osteochondrodysplasia]], [[myotonic dystrophy]], [[Yunis-Varon syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Friedreich's ataxia]], [[MELAS]], [[myotonic dystrophy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional / Metabolic''' | | '''Nutritional / Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cytochrome c oxidase deficiency]], dihydrolipoamide dehydrogenase deficiency, [[Fabry's disease]], [[long-chain acyl-CoA dehydrogenase deficiency]], [[malonyl-CoA decarboxylase deficiency]], [[MELAS]], [[glycogen synthase|muscle glycogen synthase deficiency]], [[very long-chain acyl-CoA dehydrogenase deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 95: | Line 95: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Costello syndrome]], [[hypertrichotic osteochondrodysplasia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 127: | Line 127: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Aging]], [[idiopathic]] | ||
|- | |- | ||
|} | |} |
Revision as of 02:37, 3 November 2014
Hypertrophic Cardiomyopathy Microchapters |
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hypertrophic cardiomyopathy causes On the Web |
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
Risk calculators and risk factors for Hypertrophic cardiomyopathy causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Overview
Hypertrophic cardiomyopathy is a condition that is most often passed down through families (inherited). It is thought to result from gene mutations that control heart muscle growth.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Causes by Organ System
Causes in Alphabetical Order
- Aging
- Atrial myxoma
- Cardiofaciocutaneous syndrome
- Congenital generalized lipodystrophy type 2
- Costello syndrome
- Cytochrome c oxidase deficiency
- Diabetes mellitus
- Dihydrolipoamide dehydrogenase deficiency
- Fabry's disease
- Familial
- Friedreich's ataxia
- Gene mutation
- Glycogenosis type 2
- Hereditary spherocytosis
- Hypertension
- Hypertrichotic osteochondrodysplasia
- Idiopathic
- Long-chain acyl-CoA dehydrogenase deficiency
- Malonyl-CoA decarboxylase deficiency
- MELAS
- Multiple lentigines syndrome
- Muscle glycogen synthase deficiency
- Myotonic dystrophy
- Noonan syndrome
- Sarcomeric protein mutations
- Subendocardial ischemia
- Thyroid disease
- Very long-chain acyl-CoA dehydrogenase deficiency
- Yunis-Varon syndrome